ARCHIVES

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007

Gates, Bloomberg Fund Project To Reduce Tobacco Use.

July 25, 2008

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005

Congressman Requests GAO Inquiry into FDA Foreign Inspections

April 19, 1996